PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, Portugal.\', \'REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, Portugal.\', \'School of Engineering and Sciences, Tecnologico de Monterrey, Monterrey, Mexico.\', \'Department of Nanoengineering, University of California, San Diego, San Diego, United States.\', \'Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK.\', \'Department of Mechanical and Aerospace Engineering, University of California Irvine, Engineering Gateway 4200, Irvine, United States.\', \'Department of Bioengineering, University of California, San Diego, United States.\', \'Department of Radiology, UC San Diego Health, University of California, San Diego, United States.\', \'Center for Nano-ImmunoEngineering (Nanoie), University of California, San Diego, United States.\', \'Moores Cancer Center, UC San Diego Health, University of California, San Diego, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/17425247.2021.1922387
?:doi
?:hasPublicationType
?:journal
  • Expert opinion on drug delivery
is ?:pmid of
?:pmid
?:pmid
  • 33944644
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.432
?:rankingScore_hIndex
  • 81
is ?:relation_isRelatedTo_publication of
?:title
  • Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all